Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Liver Transpl. 2017 Jun;23(6):769–780. doi: 10.1002/lt.24703

TABLE 4.

Causes of Death After Primary LT and Re-LT in Patients With PSC

Primary LT
(n = 1248)
All Re-LT
(n = 229)
P Value Early Re-LT
(n = 65)
Late Re-LT
(n = 164)
P Value
INF 210 (18.1) 68 (31.1) <0.001 19 (30.2) 49 (31.4) 0.86
Multisystem organ failure 134 (11.6) 33 (15.1) 0.15 9 (14.3) 24 (15.4) 0.84
GF 117 (10.1) 31 (14.2) 0.08 7 (11.1) 24 (15.4) 0.41
Cardiovascular 118 (10.2) 25 (11.4) 0.59 6 (9.5) 19 (12.2) 0.58
Malignancy 240 (20.7) 16 (7.3) <0.001 7 (11.1) 9 (5.8) 0.17
Hemorrhage 54 (4.7) 13 (5.9) 0.42 4 (6.4) 9 (5.8) 0.87
Renal failure 51 (4.4) 4 (1.8) 0.07 1 (1.6) 3 (1.9) 0.87
Pulmonary 41 (3.5) 3 (1.4) 0.09 0 3 (1.9) 0.27
Other 160 (13.8) 46 (21.0) 0.01 7 (11.1) 39 (25.0) 0.02

NOTE: Data are given as n (%). Cause of death was reported for 1158/1248 primary LT mortalities and 219/229 re-LT mortalities, including 63/65 for early re-LT and 156/164 for late re-LT. Up to 3 contributing causes of death could be reported.